Top Story

Common ADHD drugs may increase psychosis risk in teens, young adults

March 20, 2019
FDA News

FDA approves Adhansia XR for ADHD

March 1, 2019
The FDA has approved Adhansia XR extended-release capsules CII, a central nervous system stimulant, for the treatment of ADHD in certain patients aged 6 years and older…
In the Journals

ADHD symptoms predict impaired adaptive behavior in children with autism

February 22, 2019
Among children with autism spectrum disorder, study findings revealed that ADHD symptoms were linked to poorer adaptive behavior across all settings and after…
In the Journals

Dasotraline improves ADHD symptoms in children aged 6 to 12 years

February 12, 2019
Treatment with daily dasotraline 4 mg significantly improved ADHD symptoms and behaviors in children aged 6 to 12 years, according to a 6- week, placebo-controlled…
More Headlines »
CME Article

Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?

Psychiatric Annals, June 2017, Volume 47 Issue 6
Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent and chronic neurodevelopmental disorder often…
More »

Adult ADHD: July 2018

AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals

More »
Meeting News

VIDEO: What’s new in ADHD medications

October 21, 2016
More »
Healio Jobs